Trial
NCT03929497
Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Schizophrenia
Intervention
Lu AF11167
Why stopped
Lack of efficacy based on the interim analysis in the 17972A study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-23